Viking Therapeutics Inc (VKTX)
42.25
+0.76
(+1.83%)
USD |
NASDAQ |
Dec 20, 16:00
42.91
+0.66
(+1.56%)
After-Hours: 06:42
Viking Therapeutics Cash from Investing (Quarterly): 25.90M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Eli Lilly and Co | -4.005B |
| Pfizer Inc | -2.057B |
| Merck & Co Inc | -3.845B |
| Vertex Pharmaceuticals Inc | -348.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.96M |
| Cash from Financing (Quarterly) | 2.522M |
| Free Cash Flow | -74.25M |
| Free Cash Flow Per Share (Quarterly) | -0.198 |
| Free Cash Flow Yield | -1.65% |